Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.
暂无分享,去创建一个
Gianluca Bontempi | Benjamin Haibe-Kains | R. Kiss | C. Decaestecker | J. Ruysschaert | C. Lonez | F. Lefranc | C. Bruyère | M. Le Mercier | M. Rynkowski | B. Le Calvé | T. Gras | Céline Bruyère | Thierry Gras